Your browser doesn't support javascript.
Myopericarditis After mRNA COVID-19 Vaccine in a Patient With Recent History of COVID-19.
Elhouderi, Eiman; Elsawalhy, Eman; Kabbani, Mohamed.
  • Elhouderi E; Internal Medicine, Beaumont Health, Dearborn, USA.
  • Elsawalhy E; Internal Medicine, Beaumont Health, Dearborn, USA.
  • Kabbani M; Internal Medicine, Beaumont Health, Dearborn, USA.
Cureus ; 14(5): e25264, 2022 May.
Article in English | MEDLINE | ID: covidwho-2006482
ABSTRACT
Myopericarditis has been identified as a potential adverse event of several vaccines in the medical literature. Here we present a case of a 30-year-old male who had myopericarditis a week after receiving the second booster dose of the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine. The patient's clinical course was not severe and had a full recovery after a week of treatment.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines Language: English Journal: Cureus Year: 2022 Document Type: Article Affiliation country: Cureus.25264

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Prognostic study Topics: Vaccines Language: English Journal: Cureus Year: 2022 Document Type: Article Affiliation country: Cureus.25264